Article Text

Download PDFPDF
Evidence of oxidative stress in Schnyder corneal dystrophy
  1. Z Gatzioufas1,
  2. P Charalambous1,
  3. U Loew1,
  4. V Kozobolis2,
  5. F Schirra1,
  6. M Krause1,
  7. B Seitz1
  1. 1Department of Ophthalmology, University of Saarland, Homburg, Germany
  2. 2Department of Ophthalmology, Democritus University of Thrace, Alexandroupolis, Greece
  1. Correspondence to Zisis Gatzioufas, Department of Ophthalmology, University of Saarland, Kirrberger Strasse, 66421 Homburg, Germany; zisis.gatzioufas{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Schnyder corneal dystrophy (SCD) is a rare, autosomal, dominantly inherited corneal disorder affecting the central and peripheral cornea and is characterised by cholesterol and phospholipid deposition in the corneal epithelium and stroma, leading to progressive corneal opacification, which may result in glare and disproportionate loss of photopic vision.1–3

Nitric oxide serves as a mediator in diverse and complex cellular processes throughout the eye.4 Increased production of nitric oxide, however, can lead to cytotoxic effects mediated by peroxynitrate, a potent oxidant that finally forms the stable product nitrotyrosine (NT). NT is considered a specific marker for nitrogen-related oxidants; therefore, its presence provides evidence of oxidative damage.5 Malondialdehyde (MDA) is the end product of free-radical–initiated lipid peroxidation, indicating oxygen-dependent degradation of cholesterol and phospholipids.6 7 In view of this evidence, the aim of our study was to examine the possible contribution of the nitric oxide pathway and lipid peroxidation to the pathogenesis of SCD.

We examined three eyes from three patients with SCD who underwent a penetrating keratoplasty (PK) in our department (figure 1). The demographic and clinical data of the patients …

View Full Text


  • This study was presented as Poster at the ARVO Congress 2008.

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval This study was conducted with the approval of the ethics committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.